These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30058787)

  • 1. CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
    Niewiński PA; Wojciechowski R; Śliwiński M; Hurkacz ME; Głowacka K; Orzechowska-Juzwenko K; Wiela-Hojeńska AK
    Adv Clin Exp Med; 2018 Nov; 27(11):1499-1503. PubMed ID: 30058787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
    Candiotti KA; Birnbach DJ; Lubarsky DA; Nhuch F; Kamat A; Koch WH; Nikoloff M; Wu L; Andrews D
    Anesthesiology; 2005 Mar; 102(3):543-9. PubMed ID: 15731591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of Postoperative Nausea and Vomiting.
    Aroke EN; Hicks TL
    J Perianesth Nurs; 2019 Dec; 34(6):1088-1105. PubMed ID: 31227296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.
    Black K; Brenn BR; Gaedigk A; Wanderer JP; Van Driest SL
    Clin Transl Sci; 2023 Feb; 16(2):269-278. PubMed ID: 36350309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.
    Kaiser R; Sezer O; Papies A; Bauer S; Schelenz C; Tremblay PB; Possinger K; Roots I; Brockmöller J
    J Clin Oncol; 2002 Jun; 20(12):2805-11. PubMed ID: 12065557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
    Edwards A; Teusink-Cross A; Martin LJ; Prows CA; Mehta PA; Ramsey LB
    Clin Transl Sci; 2022 Mar; 15(3):610-618. PubMed ID: 34670017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
    Janicki PK
    Med Sci Monit; 2005 Oct; 11(10):RA322-8. PubMed ID: 16192915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.
    Wesmiller SW; Henker RA; Sereika SM; Donovan HS; Meng L; Gruen GS; Tarkin IS; Conley YP
    Biol Res Nurs; 2013 Oct; 15(4):382-9. PubMed ID: 22718526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
    Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous ondansetron as antiemetic prophylaxis for postoperative nausea and vomiting after shoulder arthroscopy.
    Chen YF; Yeh WL; Lee KH; Li MC; Yang TH; Huang HC; Huang TB; Ho HY
    Chang Gung Med J; 2011; 34(2):205-12. PubMed ID: 21539763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 isoenzyme and ABCB1 gene polymorphisms associated with postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy: a randomized trial.
    Ribeiro AHS; Braga ELC; Ferreira NAG; Olej B; Verçosa N; Antunes LDS; Cavalcanti IL
    Braz J Anesthesiol; 2024; 74(3):744423. PubMed ID: 36841429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.
    Theodosopoulou P; Rekatsina M; Staikou C
    Minerva Anestesiol; 2023 Jun; 89(6):565-576. PubMed ID: 36852569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting.
    He H; Yin JY; Xu YJ; Li X; Zhang Y; Liu ZG; Zhou F; Zhai M; Li Y; Li XP; Wang Y; Zhou HH; Liu ZQ
    Clin Ther; 2014 Aug; 36(8):1242-1252.e2. PubMed ID: 25012726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.
    Rauers NI; Stüber F; Lee EH; Musshoff F; Fimmers R; Barann M; Stamer UM
    J Pain; 2010 Dec; 11(12):1274-81. PubMed ID: 20488759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.
    Habib AS; Gan TJ
    J Clin Anesth; 2005 Feb; 17(1):62-5. PubMed ID: 15721732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.
    Janicki PK; Schuler HG; Jarzembowski TM; Rossi M
    Anesth Analg; 2006 Apr; 102(4):1127-33. PubMed ID: 16551910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron and Granisetron for prevention of postoperative nausea and vomiting following laparoscopic cholecystectomy.
    Gauchan S; Thapa C; Shakya P; Bhattarai R; Shakya S
    JNMA J Nepal Med Assoc; 2014; 52(193):682-6. PubMed ID: 26905548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
    Bell GC; Caudle KE; Whirl-Carrillo M; Gordon RJ; Hikino K; Prows CA; Gaedigk A; Agundez J; Sadhasivam S; Klein TE; Schwab M
    Clin Pharmacol Ther; 2017 Aug; 102(2):213-218. PubMed ID: 28002639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.